Tin tức & Cập nhật

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status
Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status
11 Feb 2023

Neither vulvovaginal candidiasis nor bacterial vaginosis is associated with increased incidence of cervical cytologic abnormalities among women with or without human papillomavirus (HPV) infection, according to a study. Bacterial vaginosis may even have a protective effect against cytologic abnormalities among women with HPV coinfection.

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status
11 Feb 2023
Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab
Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab
09 Feb 2023

In the treatment of hospitalized patients with COVID-19, survival outcomes appear to be more favourable with the 8-mg/kg tocilizumab regimen than with the fixed-dose tocilizumab regimen or sarilumab, according to a study.

Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab
09 Feb 2023
Studies support vedolizumab benefit for IBD
Studies support vedolizumab benefit for IBD
07 Feb 2023 bởiAudrey Abella

Data presented at the Crohn’s & Colitis Congress (CCC) 2023 reflect the benefit of vedolizumab for inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis), be it alone or in a combination regimen. In one study however, extraintestinal manifestations were observed following vedolizumab use.

Studies support vedolizumab benefit for IBD
07 Feb 2023
Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
03 Feb 2023
Study supports safety of fourth BNT162b2 mRNA vaccine
Study supports safety of fourth BNT162b2 mRNA vaccine
01 Feb 2023